We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+27.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$197M
AUM Growth
-$76M
Cap. Flow
-$97.6M
Cap. Flow %
-49.58%
Top 10 Hldgs %
44.5%
Holding
160
New
26
Increased
14
Reduced
15
Closed
66

Top Buys

Rank Stock Value
1
ATXS
Astria Therapeutics
ATXS
+$9.39M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$4.07M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.73M
4
OTLK icon
Outlook Therapeutics
OTLK
+$3.62M
5
REPL icon
Replimune Group
REPL
+$3.32M

Top Sells

Rank Stock Value
1
CCXI
ChemoCentryx, Inc.
CCXI
+$8.27M
2
INSM icon
Insmed
INSM
+$5.77M
3
MBTC
Nocturne Acquisition Corporation Ordinary Shares
MBTC
+$5.17M
4
BCAB icon
BioAtla
BCAB
+$4.26M
5
ILMN icon
Illumina
ILMN
+$4.2M

Sector Composition

Rank Sector Weight
1 Healthcare 88.67%
2 Financials 5.8%
3 Communication Services 0.42%
4 Industrials 0.36%
5 Materials 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATBW
51
DELISTED
FAT Brands Inc. Warrant
FATBW
$683K 0.35%
227,000
– –
RXST icon
52
RxSight
RXST
$260M
$641K 0.33%
+50,586
New +$615K
POL
53
DELISTED
Polished.com Inc.
POL
$578K 0.29%
+20,016
New +$600K
PEPG icon
54
PepGen
PEPG
$197M
$535K 0.27%
40,000
– –
GSRMU
55
DELISTED
GSR II Meteora Acquisition Corp. Unit
GSRMU
$529K 0.27%
50,000
– –
DDI
56
DoubleDown Interactive
DDI
$588M
$514K 0.26%
60,876
– –
OHAA
57
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$501K 0.25%
50,000
-50,000
-50% -$500K
PSQH icon
58
PSQ Holdings
PSQH
$14.7M
$497K 0.25%
3,333
– –
POL.WS
59
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$488K 0.25%
6,103,824
– –
MDWD icon
60
MediWound
MDWD
$185M
$368K 0.19%
27,286
-155,135
-85% -$1.57M
KURA icon
61
Kura Oncology
KURA
$850M
$350K 0.18%
+28,198
New +$410K
ABEO icon
62
Abeona Therapeutics
ABEO
$413M
$335K 0.17%
+108,696
New +$407K
TRKA
63
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$310K 0.16%
+106,906
New +$589K
ZEV
64
DELISTED
Lightning eMotors, Inc.
ZEV
$213K 0.11%
+29,093
New +$557K
WLDSW icon
65
Wearable Devices Ltd Warrant
WLDSW
$132K
$171K 0.09%
1,961
– –
DRCTW
66
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$140K 0.07%
180,000
– –
ATXS
67
CALL
DELISTED
Astria Therapeutics
ATXS
$115K 0.06%
+7,700
New +$79.4K
OBIO icon
68
Orchestra BioMed
OBIO
$254M
$99.8K 0.05%
10,000
– –
NEXRW
69
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$79.3K 0.04%
480,770
+240,385
+100% +$45.9K
CINGW icon
70
Cingulate Inc Warrants
CINGW
$33.2K
$64.8K 0.03%
270,000
– –
ONFOW icon
71
Onfolio Holdings Warrant
ONFOW
$64.5K
$48K 0.02%
200,000
– –
HCDIZ
72
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$38.9K 0.02%
650,000
– –
MBTCR
73
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$38.9K 0.02%
500,000
– –
NLSPW
74
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$38K 0.02%
200,000
– –
NXGLW icon
75
NexGel Inc Warrant
NXGLW
$33.8K 0.02%
225,000
– –
1 2
3
4 5

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Altium Capital Management held 160 positions worth $197M, down 28% from $273M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Altium Capital Management withdrew a net $97.6M in Q4 2022, closing 66 positions and reducing 15 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $8.27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 79% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Altium Capital Management opened a new position in Tandem Diabetes Care worth $4.05M.

  • Altium Capital Management's largest Q4 2022 buy was Tandem Diabetes Care: 90,000 shares worth $4.05M.
  • Altium Capital Management added most to Astria Therapeutics in Q4 2022, an estimated $9.39M increase.
  • Altium Capital Management's biggest Q4 2022 reduction was Chinook Therapeutics, Inc. Common Stock, cutting an estimated $3.1M.
  • Altium Capital Management fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $8.27M.
  • Altium Capital Management's ten largest holdings make up 45% of its $197M portfolio in Q4 2022.
  • Altium Capital Management opened 26 new positions and closed 66 in Q4 2022.
  • Altium Capital Management's portfolio value fell 28% quarter-over-quarter to $197M.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.